CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% |
| Q1 2021 | $46,323,000 | +2.4% | 49,064,000 | 0.0% | 0.97% | +8.9% |
| Q4 2020 | $45,236,000 | +2.5% | 49,064,000 | 0.0% | 0.89% | -16.8% |
| Q3 2020 | $44,114,000 | +0.2% | 49,064,000 | 0.0% | 1.07% | -16.2% |
| Q2 2020 | $44,037,000 | +1.0% | 49,064,000 | 0.0% | 1.28% | -7.3% |
| Q1 2020 | $43,581,000 | +1.6% | 49,064,000 | 0.0% | 1.38% | +1.0% |
| Q4 2019 | $42,905,000 | +1.5% | 49,064,000 | 0.0% | 1.37% | -20.5% |
| Q3 2019 | $42,262,000 | +165.8% | 49,064,000 | +172.6% | 1.72% | +201.8% |
| Q2 2019 | $15,902,000 | +242.2% | 18,000,000 | +260.0% | 0.57% | +220.8% |
| Q1 2019 | $4,647,000 | -72.6% | 5,000,000 | -69.7% | 0.18% | -74.5% |
| Q4 2016 | $16,979,000 | – | 16,500,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $44,037,000 | 1.28% |
| United Asset Strategies, Inc. | 1,955,000 | $1,758,000 | 0.35% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,992,000 | $1,773,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,664,000 | $2,398,000 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,170,000 | $1,953,000,000 | 0.04% |
| MACKAY SHIELDS LLC | 110,000 | $101,000 | 0.00% |
| UBS Group AG | 3,000 | $3,000 | 0.00% |
| NOMURA HOLDINGS INC | 68,267 | $5,000 | 0.00% |
| ROYAL BANK OF CANADA | 1,000 | $1,000 | 0.00% |
| FMR LLC | 1,728,000 | $1,556,000 | 0.00% |